JINZANGHUANG TIBET PHARMACEUTICALS, INC.
CIK 0000910832
Revenue (TTM)
$14.35M
Q3 May 2013
Net Income (TTM)
$7.71M
+230.1% YoY
Q3 May 2013
EPS Diluted (TTM)
—
Q3 May 2013
Gross Margin
78.7%
Q3 May 2013
Operating Margin
75.9%
Q3 May 2013
Net Margin
53.7%
Q3 May 2013
Free Cash Flow (TTM)
$6.06M
Q3 May 2013
Cash
$5.25M
Q3 May 2013
Total Debt
—
Q3 May 2013
Shares Outstanding
50.67M sh
Q3 May 2013
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.